Cart
sales@molnova.com
Methyl 2,4-dihydroxyphenylacetate
CAS No. 67828-42-6
Methyl 2,4-dihydroxyphenylacetate( —— )
Catalog No. M28968 CAS No. 67828-42-6
Methyl 2,4-dihydroxyphenylacetate is a natural product isolated from Nigella damascena seeds with selective phytotoxic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 10MG | 42 | In Stock |
|
| 25MG | 67 | In Stock |
|
| 50MG | 91 | In Stock |
|
| 100MG | 138 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethyl 2,4-dihydroxyphenylacetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl 2,4-dihydroxyphenylacetate is a natural product isolated from Nigella damascena seeds with selective phytotoxic effects.
-
DescriptionMethyl 2,4-dihydroxyphenylacetate is a natural product isolated from Nigella damascena seeds with selective phytotoxic effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPARP1|ARTD-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67828-42-6
-
Formula Weight182.175
-
Molecular FormulaC9H10O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (548.94 mM)
-
SMILESCOC(=O)Cc1ccc(O)cc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Haikarainen T, et al. Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors.ACS Med Chem Lett.?2013?Nov 20;5(1):18-22.
molnova catalog
related products
-
Lyoniside
Lyoniside and saracoside are cytotoxic to promastigotes and intracellular amastigotes, they demonstrate strong anti-leishmanial efficacies in BALB/c mice model of leishmaniasis, suggests that these two compounds potential anti-leishmanial candidates.
-
N-Formyl-Met-Leu-Phe...
N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.
-
Compound C108
Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.
